In its continuing quest to push the message of aggressive FCPA enforcement, the SEC resolved FCPA charges against Orthofix, a medical device company, for $6 million in penalties and disgorgement. In a related action, the SEC announced that Orthofix and four executives agreed to pay $8 million for accounting control errors. The Justice Department declined to prosecute Orthofix. All of this sounds reasonable, except for...